BWA vs IBRX · P/E 41, rev $7.18B vs rev $51.2M
BorgWarner Inc (BWA) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
BorgWarner Inc (BWA) is a auto parts company listed on NYSE.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported BWA revenue for 2026-06-30 was $7.18B. Net income was $519.0M. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
BWA currently screens at market cap $14.47B and trailing P/E 41.0. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the BWA and IBRX stock pages for the full models.
Not investment advice.